Personal information

No personal information available

Activities

Collapse all

Employment (5)

Shaare Zedek Medical Center: Jerusalem, Jerusalen, IL

2016-05-01 to present | Study coordinator (Gaucher unit)
Employment
Source: Self-asserted source
Michal Becker- Cohen

Hadassah Mount Scopus University Hospital: Jerusalem, Jerusalem, IL

2008-01-01 to present | Technician (Laboratories)
Employment
Source: Self-asserted source
Michal Becker- Cohen

Hadassah Mount Scopus University Hospital: Jerusalem, Jerusalem, IL

2005-01-01 to 2016-04-30 | Laboratory management (Gene Therapy, Goldyne Savad Institute)
Employment
Source: Self-asserted source
Michal Becker- Cohen

GlaxoSmithKline: Petah Tikva, IL

1999-01-01 to 2002-09-30 | Medical sales representative (Asthma products group)
Employment
Source: Self-asserted source
Michal Becker- Cohen

Agis industries LTD: Bnei Brak, IL

1997-01-01 to 1998-12-31 | Medical sales representative (Dermatology products group)
Employment
Source: Self-asserted source
Michal Becker- Cohen

Education and qualifications (3)

Hebrew University of Jerusalem: Jerusalem, Please select..., IL

2018-10-17 to present | Studies towards a PhD (Public health)
Education
Source: Self-asserted source
Michal Becker- Cohen

Hebrew University of Jerusalem Faculty of Science: Jerusalem, Jerusalem, IL

2002-10-12 to 2005-08-08 | M.Sc (Genetics)
Education
Source: Self-asserted source
Michal Becker- Cohen

Hebrew University of Jerusalem Faculty of Science: Jerusalem, Jerusalem, IL

1993-10-08 to 1996-08-14 | B.Sc (Biology)
Education
Source: Self-asserted source
Michal Becker- Cohen

Works (29)

Rapid home therapy infusion of velaglucerase alfa in naïve patients with Gaucher disease

Internal Medicine Journal
2024-03 | Journal article
DOI: 10.1111/imj.16179
Contributors: Michal Becker‐Cohen; Shoshana Revel‐Vilk; Dafna Frydman; Tama Dinur; Maayan Tiomkin; Majdolen Istaiti; Naama Arbel; Peter Bauer; Claudia Cozma; Arndt Rolfs et al.
Source: check_circle
Crossref

Has Parkinson Disease Gone to the Dogs?

Movement Disorders
2023-02 | Journal article
DOI: 10.1002/mds.29270
Contributors: Michal Becker‐Cohen; Ari Zimran; David Arkadir; Shoshana Revel‐Vilk; Uri Bakeman; Jeff Szer
Source: check_circle
Crossref

A Comprehensive Assessment of Qualitative and Quantitative Prodromal Parkinsonian Features in Carriers of Gaucher Disease-Identifying Those at the Greatest Risk.

International journal of molecular sciences
2022-10-13 | Journal article
DOI: 10.3390/ijms232012211
PMID: 36293067
PMC: PMC9603254
Contributors: Michal Becker- Cohen; Becker-Cohen M; Zimran A; Dinur T; Tiomkin M; Cozma C; Rolfs A; Arkadir D; Shulman E; Manor O et al.
Source: Self-asserted source
Michal Becker- Cohen

Rapid velaglucerase alfa infusion for Gaucher disease: 5-year data.

Internal medicine journal
2022-09-01 | Journal article
DOI: 10.1111/imj.15898
PMID: 36100564
Contributors: Michal Becker- Cohen; Becker-Cohen M; Jeff Szer; Arbel N; Frydman D; Dinur T; Istaiti M; Shoshana Revel-Vilk; Zimran A
Source: Self-asserted source
Michal Becker- Cohen

Gaucher Disease Diagnosis Using Lyso-Gb1 on Dry Blood Spot Samples: Time to Change the Paradigm?

International journal of molecular sciences
2022-01-30 | Journal article
DOI: 10.3390/ijms23031627
PMID: 35163551
PMC: PMC8835963
Contributors: Michal Becker- Cohen; Dinur T; Bauer P; Christian Beetz; Kramp G; Cozma C; Iurașcu MI; Becker-Cohen M; Majdolen Istaiti; Rolfs A et al.
Source: Self-asserted source
Michal Becker- Cohen

Pre Clinical Assessment of AAVrh74.MCK.GNE Viral Vector Therapeutic Potential: Robust Activity Despite Lack of Consistent Animal Model for GNE Myopathy.

Journal of neuromuscular diseases
2022-01-01 | Journal article
DOI: 10.3233/jnd-210755
PMID: 34806613
Contributors: Michal Becker- Cohen; Mitrani-Rosenbaum S; Yakovlev L; Becker Cohen M; Argov Z; Fellig Y; Harazi A
Source: Self-asserted source
Michal Becker- Cohen

Platelet Activation and Reactivity in a Large Cohort of Patients with Gaucher Disease.

Thrombosis and haemostasis
2021-11-05 | Journal article
DOI: 10.1055/a-1642-4206
PMID: 34507369
Contributors: Michal Becker- Cohen; Shoshana Revel-Vilk; Naamad M; Frydman D; Michael Ron Freund; Dinur T; Istaiti M; Becker-Cohen M; Falk R; Broide E et al.
Source: Self-asserted source
Michal Becker- Cohen

Impact of Long-Term Enzyme Replacement Therapy on Glucosylsphingosine (Lyso-Gb1) Values in Patients with Type 1 Gaucher Disease: Statistical Models for Comparing Three Enzymatic Formulations.

International journal of molecular sciences
2021-07-19 | Journal article
DOI: 10.3390/ijms22147699
PMID: 34299318
PMC: PMC8307068
Contributors: Michal Becker- Cohen; Tama Dinur; Ulrike Grittner; Shoshana Revel-Vilk; Becker-Cohen M; Majdolen Istaiti; Cozma C; Rolfs A; Ari ZIMRAN
Source: Self-asserted source
Michal Becker- Cohen

Upgrading the evidence for the use of ambroxol in Gaucher disease and GBA related Parkinson: Investigator initiated registry based on real life data.

American journal of hematology
2021-03-11 | Journal article
DOI: 10.1002/ajh.26131
PMID: 33606887
Contributors: Michal Becker- Cohen; Majdolen Istaiti; Shoshana Revel-Vilk; Becker-Cohen M; Tama Dinur; Ramaswami U; Daniela Castillo-Garcia; Ceron-Rodriguez M; Chan A; Rodic P et al.
Source: Self-asserted source
Michal Becker- Cohen

Parkinson's Clustering in Families of Non-Neuronopathic N370S GBA Mutation Carriers Indicates the Presence of Genetic Modifiers.

Journal of Parkinson's disease
2021-01-01 | Journal article
DOI: 10.3233/jpd-202422
PMID: 33612495
Contributors: Michal Becker- Cohen; Dinur T; Becker-Cohen M; Revel-Vilk S; Zimran A; Arkadir D
Source: Self-asserted source
Michal Becker- Cohen

Patient reported outcome measures in a large cohort of patients with type 1 Gaucher disease.

Orphanet journal of rare diseases
2020-10-13 | Journal article
DOI: 10.1186/s13023-020-01544-z
PMID: 33050940
Contributors: Michal Becker- Cohen; Dinur T; Istaiti M; Frydman D; Becker-Cohen M; Szer J; Zimran A; Shoshana Revel-Vilk
Source: Self-asserted source
Michal Becker- Cohen

Macular Ganglion Cell Complex and Peripapillary Retinal Nerve Fiber Layer Thinning in Patients with Type-1 Gaucher Disease.

International journal of molecular sciences
2020-09-24 | Journal article
DOI: 10.3390/ijms21197027
PMID: 32987733
PMC: PMC7582605
Contributors: Michal Becker- Cohen; Yishay Weill; Ari ZIMRAN; Zadok D; Wasser LM; Shoshana Revel-Vilk; Hanhart J; Dinur T; Arkadir D; Becker-Cohen M
Source: Self-asserted source
Michal Becker- Cohen

The glycomic sialylation profile of GNE Myopathy muscle cells does not point to consistent hyposialylation of individual glycoconjugates.

Neuromuscular disorders : NMD
2020-06-04 | Journal article
DOI: 10.1016/j.nmd.2020.05.008
PMID: 32736841
Contributors: Michal Becker- Cohen; Sela I; Goss V; Becker-Cohen M; Dell A; Haslam SM; Stella Mitrani-Rosenbaum
Source: Self-asserted source
Michal Becker- Cohen

Response of ophthalmologists in Israel to the novel coronavirus (2019-nCoV) outbreak.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
2020-04-28 | Journal article
DOI: 10.1007/s00417-020-04694-9
PMID: 32346785
PMC: PMC7186536
Contributors: Michal Becker- Cohen; Lauren Wasser; Assayag E; Maria Tsessler; Weill Y; Becker-Cohen M; Zadok D
Source: Self-asserted source
Michal Becker- Cohen

Upregulation of Hallmark Muscle Genes Protects GneM743T/M743T Mutated Knock-In Mice From Kidney and Muscle Phenotype.

Journal of neuromuscular diseases
2020-01-01 | Journal article
DOI: 10.3233/jnd-190461
PMID: 31985472
PMC: PMC7175939
Contributors: Michal Becker- Cohen; Benyamini H; Kling Y; Yakovlev L; Becker Cohen M; Nevo Y; Elgavish S; Harazi A; Argov Z; Sela I et al.
Source: Self-asserted source
Michal Becker- Cohen

Long Term Follow-Up of 103 Untreated Adult Patients with Type 1 Gaucher Disease.

Journal of clinical medicine
2019-10-11 | Journal article
DOI: 10.3390/jcm8101662
PMID: 31614613
PMC: PMC6832634
Contributors: Michal Becker- Cohen; Dinur T; Zimran A; Becker-Cohen M; Arkadir D; Cozma C; Hovakimyan M; Oppermann S; Demuth L; Rolfs A et al.
Source: Self-asserted source
Michal Becker- Cohen

Glucosylsphingosine (lyso-Gb1) as a Biomarker for Monitoring Treated and Untreated Children with Gaucher Disease.

International journal of molecular sciences
2019-06-21 | Journal article
DOI: 10.3390/ijms20123033
PMID: 31234327
PMC: PMC6627663
Contributors: Michal Becker- Cohen; Hurvitz N; Dinur T; Becker-Cohen M; Cozma C; Hovakimyan M; Oppermann S; Demuth L; Rolfs A; Abramov A et al.
Source: Self-asserted source
Michal Becker- Cohen

Prodromal substantia nigra sonography undermines suggested association between substrate accumulation and the risk for GBA-related Parkinson's disease.

European journal of neurology
2019-03-01 | Journal article
DOI: 10.1111/ene.13927
PMID: 30714262
Contributors: Michal Becker- Cohen; David Arkadir; Dinur T; Becker Cohen M; Revel-Vilk S; Tiomkin M; Norbert Brüggemann; Cozma C; Rolfs A; Zimran A
Source: Self-asserted source
Michal Becker- Cohen

Rapid intravenous infusion of velaglucerase-alfa in adults with type 1 Gaucher disease.

American journal of hematology
2018-08-09 | Journal article
DOI: 10.1002/ajh.25205
PMID: 29989200
Contributors: Michal Becker- Cohen; Ari ZIMRAN; Shoshana Revel-Vilk; Becker-Cohen M; Chicco G; Arbel N; Rolfs A; Jeff Szer
Source: Self-asserted source
Michal Becker- Cohen
grade
Preferred source (of 2)‎

Glucosylsphingosine is a reliable response biomarker in Gaucher disease.

American journal of hematology
2018-03-15 | Journal article
DOI: 10.1002/ajh.25074
PMID: 29473199
Contributors: Michal Becker- Cohen; David Arkadir; Dinur T; Revel-Vilk S; Becker Cohen M; Cozma C; Hovakimyan M; Eichler S; Rolfs A; Ari ZIMRAN
Source: Self-asserted source
Michal Becker- Cohen

The Interaction of UDP-N-Acetylglucosamine 2-Epimerase/N-Acetylmannosamine Kinase (GNE) and Alpha-Actinin 2 Is Altered in GNE Myopathy M743T Mutant.

Molecular neurobiology
2016-03-29 | Journal article
DOI: 10.1007/s12035-016-9862-x
PMID: 27023225
Contributors: Michal Becker- Cohen; Harazi A; Becker-Cohen M; Zer H; Moshel O; Hinderlich S; Stella Mitrani-Rosenbaum
Source: Self-asserted source
Michal Becker- Cohen

Survival-apoptosis associated signaling in GNE myopathy-cultured myoblasts.

Journal of receptor and signal transduction research
2014-12-16 | Journal article
DOI: 10.3109/10799893.2014.956755
PMID: 25510413
Contributors: Michal Becker- Cohen; Harazi A; Chaouat M; Shlomai Z; Levitzki R; Becker-Cohen M; Sadeh M; Dabby R; Ben-Bassat H; Stella Mitrani-Rosenbaum
Source: Self-asserted source
Michal Becker- Cohen

Gne depletion during zebrafish development impairs skeletal muscle structure and function.

Human molecular genetics
2014-01-31 | Journal article
DOI: 10.1093/hmg/ddu045
PMID: 24488768
Contributors: Michal Becker- Cohen; Daya A; Gad Vatine; Becker-Cohen M; Tal-Goldberg T; Friedmann A; Yoav Gothilf; Jim du; Stella Mitrani-Rosenbaum
Source: Self-asserted source
Michal Becker- Cohen

Variable myopathic presentation in a single family with novel skeletal RYR1 mutation.

PloS one
2013-07-24 | Journal article
DOI: 10.1371/journal.pone.0069296
PMID: 23894444
PMC: PMC3722152
Contributors: Michal Becker- Cohen; Attali R; Aharoni S; Susan Treves; Ori Rokach; Becker Cohen M; Fellig Y; Straussberg R; Dor T; Daana M et al.
Source: Self-asserted source
Michal Becker- Cohen

Variable phenotypes of knockin mice carrying the M712T Gne mutation.

Neuromolecular medicine
2012-12-13 | Journal article
DOI: 10.1007/s12017-012-8209-7
PMID: 23238814
Contributors: Michal Becker- Cohen; Sela I; Yakovlev L; Becker Cohen M; Elbaz M; Yanay N; Ben Shlomo U; Yotvat H; Fellig Y; Argov Z et al.
Source: Self-asserted source
Michal Becker- Cohen

Sustained expression and safety of human GNE in normal mice after gene transfer based on AAV8 systemic delivery.

Neuromuscular disorders : NMD
2012-05-25 | Journal article
DOI: 10.1016/j.nmd.2012.03.013
PMID: 22633753
Contributors: Michal Becker- Cohen; Stella Mitrani-Rosenbaum; Yakovlev L; Becker Cohen M; Telem M; Elbaz M; Yanay N; Yotvat H; Ben Shlomo U; Harazi A et al.
Source: Self-asserted source
Michal Becker- Cohen

GNE is involved in the early development of skeletal and cardiac muscle.

PloS one
2011-06-24 | Journal article
DOI: 10.1371/journal.pone.0021389
PMID: 21731727
PMC: PMC3123316
Contributors: Michal Becker- Cohen; Milman Krentsis I; Sela I; rachel eiges; Veronique Blanchard; Berger M; Becker Cohen M; Stella Mitrani-Rosenbaum
Source: Self-asserted source
Michal Becker- Cohen

Mitochondrial processes are impaired in hereditary inclusion body myopathy.

Human molecular genetics
2008-08-23 | Journal article
DOI: 10.1093/hmg/ddn261
PMID: 18723858
Contributors: Michal Becker- Cohen; Eisenberg I; Noa Novershtern; Itzhaki Z; Becker-Cohen M; Sadeh M; Peter H.G.M. Willems; Nir Friedman; Werner J.H. Koopman; Stella Mitrani-Rosenbaum
Source: Self-asserted source
Michal Becker- Cohen

UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE) binds to alpha-actinin 1: novel pathways in skeletal muscle?

PloS one
2008-06-18 | Journal article
DOI: 10.1371/journal.pone.0002477
PMID: 18560563
PMC: PMC2423482
Contributors: Michal Becker- Cohen; Amsili S; Zer H; Hinderlich S; Sabine Krause; Becker-Cohen M; MacArthur DG; Kathryn North; Stella Mitrani-Rosenbaum
Source: Self-asserted source
Michal Becker- Cohen
How many people are using ORCID?